Análise dos desfechos clínicos de pacientes pediátricos com Síndrome Respiratória Aguda Grave por Vírus Sincicial Respiratório em hospital secundário do Distrito Federal

Gabriela Ramos Lopes; Lucas Mendes Gomes; Bárbara Cunha Barreto; Maria Alice Ramalho Bragatto; Simone Ferreira da Silva Marques; Flávia Kanitz

doi:10.51723/hrj.v5i24.1064

Authors

Gabriela Ramos Lopes
Lucas Mendes Gomes
Bárbara Cunha Barreto
Maria Alice Ramalho Bragatto
Simone Ferreira da Silva Marques
Flávia Kanitz

DOI:

https://doi.org/10.51723/hrj.v5i24.1064

Keywords:

Bronquiolite viral. Infecções por Vírus Respiratório Sincicial. Síndrome Respiratória Aguda Grave. Oxigenoterapia. Ventilação Mecânica

Abstract

Objective: evaluate the clinical profile of pediatric patients with SARS due to RSV during the seasonal period in a secondary care service in the Federal District. Method: this is part of the study “Severe Acute Respiratory Syndrome (SARS) in pediatrics – relationship between the etiological agents and clinical outcomes in a secondary hospital in the Federal District, between December 2021 and June 2022”, in which were only considered patients with infection by RSV, including coinfection. This is a descriptive, retrospective, cross-sectional and quantitative study, carried out by collecting data from pediatric patients hospitalized who met criteria for SARS. After collection, the data was analyzed and compared with literature data on the topic. Results: 113 patients were included, 97 of them with RSV infection and 16 with RSV co-infection. A higher incidence was observed in children under 1 year of age (65.48%, 74 cases) and between March and April 2022. Among those infected with RSV, all those under 3 months of age, those coinfected and those with comorbidities required oxygen support, with almost 33% needing NIV or MV. Among those with comorbidities, those premature were those who most frequently required NIV or MV. Conclusion: this study highlights the rate of pediatric patients with SARS caused by RSV who require respiratory support and intensive care offering support for the preparation of services and health teams to face future seasonality and reinforcing the imperativity of adopting prophylactic measures, such as the use of pavilizumab.

References

de Souza e Silva LL, Soares LP, Xavier AFV, Brandão MM, Simões SC, Chaves LP, Watanabe LDH, de Macedo AGF, Araújo Neto F da C, Nascimento FH. (2023) [Acesso em: 08 de outubro de 2023]. Bronquiolite viral: aspectos epidemiológicos, fisiopatológicos e manejo terapêutico. Brazilian Journal of Development, 9(3), 12351-12361. Disponível em: https://doi.org/10.34117/bjdv9n3-222

Lieberthal AS, Bauchner H, Hall CB, Johnson DW, Kotagal U, Light MJ, Mason W, Meissner HC, Phelan KJ, Zorc JJ, Brown MA, Clover RD, Nathanson IT, Korppi M, Shiffman RN, Stanko-Lopp D & Davidson C. (2006). Diagnosis and management of bronchiolitis. In: Pediatrics (Vol. 118, Issue 4, pp. 1774-1793). Available from: https://doi.org/10.1542/peds.2006-2223

Ministério da Saúde (BR), Secretaria de Vigilância em Saúde. Ficha de Registro Individual – Casos de Síndrome Respiratória Aguda Grave Hospitalizado [internet]; 23 de março de 2021 [Acesso em: 26 de agosto de 2022]. Disponível em: https://opendatasus.saude.gov.br/dataset/39a4995f-4a6e-440f-8c8f-b00c81fae0d0/resource/9f0edb83-f8c2-4b53-99c1-099425ab634c/download/ficha_srag_hospitalizado_23.03.2021.pdf

Alvarez AE, de Lima Marson FA, Bertuzzo CS, Arns CW & Ribeiro JD. (2013). Epidemiological and genetic characteristics associated with the severity of acute viral bronchiolitis by respiratory syncytial virus. Jornal de Pediatria, 89(6), 531-543. Available from: https://doi.org/10.1016/j.jped.2013.02.022

Hussain F, Delgado Thompson M, Vick D, West J & Edwards M. (2022). Clinical severity of RSV bronchiolitis. Health Science Reports, 5(2). Available from: https://doi.org/10.1002/hsr2.543

Presti S, Manti S, Gambilonghi F, Parisi GF, Papale M & Leonardi S. (2023). Comparative Analysis of Pediatric Hospitalizations during Two Consecutive Influenza and Respiratory Virus Seasons Post-Pandemic. Viruses, 15(9), 1825. Available from: https://doi.org/10.3390/v15091825

Chuang YC, Lin KP, Wang LA, Yeh TK & Liu PY. (2023). The Impact of the COVID-19 Pandemic on Respiratory Syncytial Virus Infection: A Narrative Review. In: Infection and Drug Resistance (Vol. 16, pp. 661-675). Dove Medical Press Ltd. Available from: https://doi.org/10.2147/IDR.S396434

Prevenção do Vírus Sincicial Respiratório. (n.d.). Disponível em: https://www.saude.df.gov.br/saude-da-crianca/

de Paulis M, Gili AE, Ferraro AA, Ferronato AE, do Sacramento PR, Botosso VF, de Oliveira DBL, Marinheiro JC, Hársi CM, Durigon EL & Vieira SE. (2011). Gravidade das coinfecções virais em lactentes hospitalizados com infecção por vírus sincicial respiratório. Jornal de Pediatria, 87(4), 307-313. Disponível em: https://doi.org/10.2223/JPED.2100

Maedel C, Kainz K, Frischer T, Reinweber M, & Zacharasiewicz A. (2018). Increased severity of respiratory syncytial virus airway infection due to passive smoke exposure. Pediatric Pulmonology, 53(9), 1299-1306. Available from: https://doi.org/10.1002/ppul.24137

Mazur NI, Terstappen J, Baral R, Bardají A, Beutels P, Buchholz UJ, Cohen C, Crowe JE, Cutland CL, Eckert L, Feikin D, Fitzpatrick T, Fong Y, Graham BS, Heikkinen T, Higgins D, Hirve S, Klugman KP, Kragten-Tabatabaie L, Bont L. (2023). Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape. In: The Lancet Infectious Diseases (Vol. 23, Issue 1, pp. e2-e21). Elsevier Ltd. Available from: https://doi.org/10.1016/S1473-3099(22)00291-2

de Ávila Kfouri R, dos Santos Rodrigues Sadeck L, Avila Moura A, Chassot Bresolin A, Lopes Miralha A, Moraes Pimentel A et al. (n.d.). Diretrizes para o manejo da infecção causada pelo vírus sincicial respiratório (VSR)-2017. Departamentos Científicos de Cardiologia, Imunizações, Infectologia, Neonatologia e Pneumologia. Colaboradores: Revisores. Disponível em: www.redeneonatal.fi

Ma S, Sumner A & Duchesne-Belanger S. (2019). Cost-effectiveness of Palivizumab for Respiratory Syncytial Virus: A Systematic Review. In Pediatrics (Vol. 143, Issue 5). Available from: http://publications.aap.org/pediatrics/article-pdf/143/5/e20184064/1076933/peds_20184064.pdf

das Neves Simas da Silva K & Henrinque de Souza K. (n.d.). Os Benefícios Da Palivizumabe Ao Evitar Hospitalização De Prematuros E Crianças Em Hospital De Alta Complexidade. The Benefits Of Palivizumabe By Avoiding Hospitalization Of Prematures And Children In A High Complexity Hospital. 6, 2022.